# Quebec SEAO #20175255

On-demand supply of approximately 15 Edwards Lifesciences Evoque systems

**Posted:** October 23, 2026
**Respond By:** November 05, 2026
**Identifier:** 20175255
**NAICS:** 423450

Santé Québec Estrie is seeking an on-demand supply of Edwards Lifesciences Evoque systems for use at CHUS Fleurimont.
- **Government buyer:** Santé Québec Estrie – Centre hospitalier universitaire de Sherbrooke (CHUS), for hemodynamics at CHUS Fleurimont.
- **OEM:** **Edwards Lifesciences** is the named manufacturer and supplier.
- **Requested product:** Approximately 15 Evoque systems, percutaneous tricuspid valve replacement devices; no part number is provided.
- **Notable requirement:** The notice states that Evoque is the only percutaneous tricuspid valve replacement device approved by Santé Canada.
- **Period of performance:** Expected contract duration is 36 months. Start date is not provided.

### Description

The notice concerns a supply-on-demand contract for the acquisition of approximately fifteen Evoque systems from Edwards Lifesciences. The systems are used in hemodynamics at CHUS Fleurimont. The notice states that Santé Canada has currently approved only one percutaneous tricuspid valve replacement device, the Evoque system from Edwards Lifesciences. The expected contract duration is 36 months; the estimated value is not provided.

[View original listing](https://seao.gouv.qc.ca/avis-resultat-recherche/consulter?ItemId=68fa765e-8bdd-4eb6-8963-145d5039224b)